Cadre Holdings Signals Confident Growth Path Ahead

Cadre Holdings, Inc. ((CDRE)) has held its Q1 earnings call. Read on for the main highlights of the call.

Cadre Holdings struck a confident tone on its latest earnings call, balancing robust growth metrics with a candid view of manageable headwinds. Management highlighted double‑digit revenue expansion, a record backlog, and reaffirmed guidance, arguing that solid demand and disciplined capital deployment leave the company well positioned despite near‑term margin and mix pressures.

Strong Quarterly Revenue Growth

Cadre reported Q1 net sales of $155.4 million, up 19% year over year, powered by recurring demand from law enforcement, first responders, military, and nuclear markets. Management stressed that this growth was broad‑based across core protection categories, underscoring the resilience of their end‑market exposure even as some discretionary items softened.

Record Orders Backlog

The company ended March with a record backlog of about $355 million, up $166 million versus the prior quarter and including $108 million of organic growth. Executives framed this backlog as a strong indicator of future revenue visibility, noting that it reflects both large program wins and steady demand in day‑to‑day duty gear.

Reaffirmed 2026 Guidance With Double‑Digit Growth

Cadre reaffirmed full‑year 2026 guidance for net sales of $736 million to $758 million and adjusted EBITDA of $136 million to $141 million, implying roughly 22% revenue growth at the midpoint. The outlook also calls for about 24% growth in adjusted EBITDA and an adjusted EBITDA margin of around 18.5%, signaling confidence in earnings power despite mix volatility.

Backlog Drivers and Conversion Visibility

Key backlog drivers include an $87 million, seven‑year blast attenuation seat contract with General Dynamics European Land Systems and strong orders in duty gear and armor. Management expects most of the backlog, excluding much of the blast‑seat award, to convert into revenue in 2026 and guided Q2 sales to roughly $178 million, highlighting solid near‑term traction.

Active and Disciplined M&A Program

M&A remains central to Cadre’s growth strategy, with two deals closed in 2026 so far: TIER Tactical for $175 million in January and Alien Gear Holsters for $10.3 million in April. Since its IPO the company has executed seven acquisitions, deploying more than $400 million since 2024, with management emphasizing both strategic fit and disciplined valuation.

Consumer Channel Strength

The consumer channel delivered 6.7% year‑over‑year growth in Q1, supported by the Safariland brand and new product launches. Cadre is now integrating Alien Gear with an eye toward sharpening its consumer positioning in holsters and related gear, aiming to build a complementary portfolio across professional and enthusiast markets.

Financial Position and Capital Allocation

Net leverage finished the quarter just under 3.0x and would sit below 2.5x on a pro forma basis with a full year of TIER earnings, aligning with a longer‑term target near 2.0x. Strong free cash flow is funding a balanced approach that includes ongoing acquisitions, debt reduction, and the company’s 17th consecutive May dividend since going public.

Margin and Cost Outlook

Q1 margins landed in line with internal expectations even as product mix shifted toward lower‑margin categories in armor and nuclear, creating some early‑year pressure. Management expects margins to grind higher through 2026 as mix improves, operating leverage builds, and more higher‑margin backlog, including specialized equipment, flows through the P&L.

Nuclear Market Opportunity (Defense‑Focused)

On the nuclear side, Cadre pointed to a U.S. Department of Energy fiscal‑2027 budget that is projected to rise around 10%, with particular strength in defense‑related spending. That trend could benefit its CAS ventilation, containment, robotic arms, and container businesses, supporting a more favorable medium‑term setup for portions of the nuclear portfolio.

Mix Headwinds Impacting Margins

Still, the company acknowledged that Q1 saw mix‑related headwinds, particularly in armor and nuclear offerings that carry lower margins than the corporate average. Leaders reiterated that these pressures should ease as the year unfolds, with scale, pricing, and a shifting sales mix expected to support improved profitability.

Softness in Company‑Owned Distribution

Cadre’s company‑owned distribution channel showed softness in discretionary third‑party items like boots, uniforms, and flashlights, especially in January. However, management said products manufactured by Cadre held up well and that overall revenues in this channel recovered in February and March, suggesting the weakness is manageable rather than structural.

Plutonium Downblending Suspension

One nuclear‑related drag remains the suspension of plutonium downblending activities, where management reported no change from prior updates. This lull could weigh on demand for certain related products in the near term, though the impact is limited to a relatively narrow slice of the overall nuclear business.

Portion of Backlog Deferred Into 2027

The $87 million blast attenuation seat award is a marquee win but will have only limited shipments in 2026, with the bulk of deliveries expected in 2027. As a result, investors should view this contract as enhancing longer‑term visibility rather than providing a near‑term revenue surge, moderating the immediate conversion of the backlog.

Alien Gear Integration and Profitability Uncertainty

Alien Gear, acquired through a bankruptcy process for $10.3 million, historically generated about $20 million of revenue with roughly 10% EBITDA margins. Cadre is still assessing how the bankruptcy may affect short‑term performance and has not yet rolled Alien Gear into formal guidance, framing 2026 as a transition year for that asset.

Forward‑Looking Guidance and Outlook

Management reiterated full‑year 2026 guidance calling for net sales of $736 million to $758 million, organic growth of 3% to 5%, and adjusted EBITDA of $136 million to $141 million, with Q2 revenue expected at about $178 million and a 17.5% margin. The company anticipates roughly 55% of full‑year revenue to land in the second half and projects mid‑20% growth in adjusted EBITDA, supported by the record backlog, healthy cash generation, and a gradually deleveraging balance sheet.

Cadre’s latest call painted a picture of a niche safety‑equipment player leaning into secular demand while absorbing pockets of short‑term volatility. With strong top‑line momentum, a swelling backlog, and disciplined dealmaking, management argued the business is on track to deliver sustained growth and margin improvement, leaving investors focused on execution rather than demand risk.